Not going to help your cred here but A+++ post!
Post# of 72440
A large short postion + apparent Mako/Rosen coordination + Aruda/Aspire (millions of shares added to the sell-side of the market in 2015 and 2016) would decimate such a thinly traded stock that was stranded on OTC under $2.
I had thought that the Merck patent debacle hurt all the ABX valuations at the time but didn't consider such nefarious dealings.
The CUSIP change plus this post should put to rest the notion of a large naked short position. Those with "simple military minds" should realize that they should provide proof when the posit a theory. The burden of proof is not on the guy refuting the theory.
Go IPIX!